eli lilly & co (LLY:New York)
Last $54.14 USD
Change Today -0.60 / -1.10%
Volume 5.0M
As of 8:04 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - eli lilly & co (LLY)
| Name | Board Relationships | Title | Age |
| John C. Lechleiter Ph.D. | 44 Relationships | Chairman, Chief Executive Officer and President | 58 |
| Derica W. Rice | 18 Relationships | Acting Chief Executive Officer, Chief Financial Officer, Executive Vice President of Global Services, Member of Operations Committee and Member of Policy & Strategy Committee | 47 |
| Melt van der Spuy | 15 Relationships | Chairman of India Operations and Managing Director of India Operations | -- |
| Alex M. Azar II | No Relationships | Member of Operations Committee, Member of Policy & Strategy Committee and President of Lilly USA | 44 |
| Enrique A. Conterno | No Relationships | Senior Vice President and President of Lilly Diabetes | 45 |
Board Members - eli lilly & co (LLY)
| Name | Board Relationships | Primary Company | Age |
| John C. Lechleiter Ph.D. | 44 Relationships | Eli Lilly and Company | 58 |
| Ellen R. Marram | 246 Relationships | KBL Healthcare Acquisition Corp III. | 65 |
| Sidney Taurel | 186 Relationships | Capital Royalty L.P | 63 |
| Melt van der Spuy | 15 Relationships | Eli Lilly and Company | -- |
| Alfred G. Gilman M.D., Ph.D. | 26 Relationships | Regeneron Pharmaceuticals, Inc. | 70 |
Executive Committees* - eli lilly & co (LLY)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Michael L. Eskew | 108 Relationships | 5 Executives |
| Compensation Committee | Karen N. Horn Ph.D. | 114 Relationships | 4 Executives |
| Corporate Governance Committee | Ellen R. Marram | 246 Relationships | 3 Executives |
| Finance Committee | Winfried Franz Wilhelm Bischoff | 67 Relationships | 5 Executives |
| Committee on Directors | Ellen R. Marram | 246 Relationships | 3 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| LLY:US | $54.14 USD | -0.60 |  |
| Company | Last | Change |
| AbbVie Inc | $45.44 USD | -1.15 |
| Amgen Inc | $105.91 USD | +0.29 |
| AstraZeneca PLC | 3,428 GBp | +1.50 |
| Bristol-Myers Squibb Co | $47.40 USD | +0.40 |
| Teva Pharmaceutical Industries Ltd | $39.34 USD | -0.15 |
| View Industry Companies | ||
Industry Analysis
LLY
Industry Average
| Valuation | LLY | Industry Range |
| Price/Earnings | 13.0x |
|
| Price/Sales | 2.6x |
|
| Price/Book | 3.9x |
|
| Price/Cash Flow | 13.2x |
|
| TEV/Sales | 2.2x |
|
Post a JobJobs
- Indianapolis, IN | ELI Lilly and CompanyPosted: May 23
- Indianapolis, IN | ELI LillyPosted: May 17
- Indianapolis, IN | ELI Lilly and CompanyPosted: May 23
- Indianapolis, IN | ELI LillyPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
